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Summary 
Interleukin 4 (IL-4) diminishes cytokine activation of human macrophage. IL-4 binding to monocyte 
IL-4R is associated with protein kinase C (PKC) translocation to a nuclear fraction. The cleavage 
of diacylglycerol (DAG), an activator of PKC, from membrane phospholipids was investigated 
to define the proximal events of IL-4R signaling. IL-4 induced a statistically  significant  time- 
and dose-dependent generation of DAG. The IL-4-triggered production of DAG was not derived 
from phosphatidylinositol 4,5-bisphosphate  (PIP2) hydrolysis, since neither cytosolic caidum flux 
nor liberation ofinositol phosphates was detected in response to IL-4. Experiments were performed 
using [14C-methyl]choline-labeled  U937  cells  and monocytes to  determine whether IL-4R 
activated  phospholipase C  (PLC), PLD, or PLA2 to use membrane phosphatidylcholine (PC) 
to form DAG. IL-4 induced a time- and dose-dependent increase ofphosphocholine (pchol) with 
concomitant degradation of membrane PC (p < 0.05 compared with control). The finding that 
the peak reduction of PC was equivalent to peak production of pchol suggested that IL-4R 
signaling involved the activation of a PC-spedfic PLC.  Changes in choline (chol)  or lyso-PC 
and glycerolphosphocholine" the respective products of PC cleavage by PLD or PLA2, were not 
detected in IL-4-treated ceils. In contrast,  exogenous PLD induced an increase  in chol and 
concomitant loss of membrane PC. Additional investigation suggested that IL-4R signaling does 
not involve PLD.  In cells labeled  with L-lyso-3-PC  1-[1-14C]palmitoyl,  PLD but  not  IL-4, 
increased the production of phosphatidic acid (PA) and phosphatidyl-ethanol when pretreated 
with ethanol. Propanolol, an inhibitor of phosphatidate phosphohydrolase, and calyculin A, a 
phosphatase 1 and 2A inhibitor, blocked DAG production in response to FMLP but not to IL-4. 
In propranolol pretreated cells, PMA but not IL-4 triggered the production of PA and lowered 
the  amount  of DAG.  Evidence  that  PLA2 is  not  coupled  to  IL-4R  is  the  detection of 
arachidonate production in response to FMLP but not to IL-4. Furthermore, IL-4R is not coupled 
to sphingomyelinase (SMase) since IL-4,  unlike exogenous SMase, did not generate ceramide 
but induced the hydrolysis of PC to pchol that was comparable to exogenous PLC. In summary, 
IL-4R signaling in monocytes and U937 cells involves PLC and not PLD, PLA2, or SMase, and 
it uses PC and not PIP2 to form DAG. 
I 
L-4 is a T  lymphocyte-derived cytokine. Although IL-4 
was originally described as a B cell growth and differenti- 
ation factor, it has pleiotropic effects on multiple ceils (1-3). 
IL-4 plays a role in the pathogenesis of leishmaniasis (4-7), 
downmodulates the immune response in parasitic and retroviral 
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infection (7), and is involved in Th-2 cell function (8). Mac- 
rophages express IL-4K, and their functions are modulated 
by this cytokine. Investigations reported by our laboratory 
and others have demonstrated that IL-4 is a potent inhibitor 
of macrophage activation by IFN-% TNF-c~, IL-1, IL-3, and 
GM-CSF for anti-leishmanial activity and oxidative burst ca- 
pacity (9). IL-4 has also been shown, in monocytes, to in- 
hibit the induction of IL-1 and TNF-a by LPS (10, 11). Since 
IL-4 affects many macrophage cell functions, investigations 
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transduction. 
The interaction between an agonist, such as cytokine, and 
its receptor triggers a cascade of second messengers that link 
extracellular signals to changes in cell function. Protein ki- 
nase C (PKC) I is one of several second messengers  involved 
in receptor signal transduction (12, 13). Upon agonist stim- 
ulation, PKC is activated by 1,2-diacylglycerol  (DAG)  (13). 
DAG is derived from hydrolysis of either phosphatidylino- 
sitol (PIP2) or phosphatidylcholine (PC) by phospholipases 
(14-17), or from exchange of phosphocholine (pchol) between 
PC  and ceramide  (18, 19). Activated PKC  transfers  P04 
from ATP to threonine and serine residues on proteins, which 
alters  their function (13). 
Although IL-4R has been cloned, the signal transduction 
pathway linking the IL-4R is not well defined (20).  PKC 
has been reported in signal transduction of epidermal growth 
factor, platelet-derived growth factor, insulin-like growth factor 
1, TNF-o~, IL-1, -2, -3, IFN-3r and -o~, and M-CSF or CSF-1 
(for reviews  see references  21  and 22).  The mechanism by 
which some PKC is activated remains incompletely defined, 
whereas others have been shown to involve PC-specific phos- 
pholipase C  (PLC; 21, 22). We have recently demonstrated 
that IL-4 binding to its receptor on human monocytes in- 
volves PKC activation and translocation to a nuclear fraction 
(22).  To characterize further the association of PKC activa- 
tion with IL-4R signaling, we investigated whether DAG 
was derived from PIP2 or PC  hydrolysis,  and determined 
which phospholipase was activated by IL-4R. 
Materials  and Methods 
Cells and their Isolation.  Human peripheralblood cells obtained 
by Hypaque-Ficoll  density centrifugation and adherence to plastic 
are ,v99% monocytes  (9). Human PMN from healthy donors were 
isolated as previously  described, by FicoU-Hypaque  density centrifu- 
gation and dextran sedimentation (23). Human monomyelocytic 
ceils, U937, were obtained from the American Type Culture Col- 
lection (RockviUe,  MD) (CRL 1593), and maintained in complete 
medium (R.PMI 1640 containing 100/~g/ml penicillin, 100/~g/ml 
streptomycin, 10 mM L-glutamine, and Hepes, pH 7.2). Murine 
CTLL cells, stably transfected with human (hu)-Ib4R. and propa- 
gated in complete medium containing Ib4 (25 ng/ml), were a 
generous gift of Dr. K. Grabstein (Immunex Research Corpora- 
tion, Seattle, WA; 9, 20). 
1,2-DAG Radioenzymatic Assay.  Cells,  treated with medium or 
medium containing stimuli and quickly chilled (4~  on ice with 
added normal saline, were pelleted by centrifugation (300 g for 10 
min). The cell pellets were extracted with chloroform/methanol 
1 Abbreviations used in this ~per: chol, choline;  DAG, diacylglycerol;  Fura- 
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inositol phosphate; IP2, inositol  biphosphate; IP3, inositol  1,4,5-triphos- 
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D; SM, sphingomyelin;  SMase, sphingomyelinase. 
(1:1 vol/vol) to which 1/4 volume of 10 mM EDTA was added 
to break phase, and the lower phase (total vol, 1.2 ml) containing 
DAG and phospholipids (PL) was used to quantitate DAG and PLs. 
For DAG quantitation, 800/~1 of the lower phase was evaporated 
under nitrogen (24). Escherichia coli DAG kinase (Lipidex,  Westfield, 
NJ) was used to catalyze the transfer of 32P04 from 3/-[32p]ATP 
to endogenous DAG, converting it to [32P]phosphatidic acid (PA) 
at equimolar ratio (25-27). The dried samples were solubilized in 
20 #1 octyl-B-D-glucoside  cardiolipin solution by sonication, fol- 
lowed by the addition of 50/~1 2 x  reaction buffer, 10/~1 dithio- 
threitol, and 10 #1 DAG kinase to a total volume of 90 ~l. The 
2x  reaction  buffer is composed of (in raM): 100 imidazole, 100 
NaC1, 25 MgC12, and 2 EGTA, pH 6.6. The addition of 10 ~1 
3~-[32p]ATP  (sp  act,  30  Ci/mM;  Amersham  Life  Sciences, 
Arlington Heights, IL) and ATP (0.34 mM) mixture initiated the 
reaction at room temperature for 30 min. The reaction was stopped 
by the addition of 3 ml chloroform/methanol (1:2, vol/vol). After 
the removal of methanol, a two-step extraction was performed by 
the addition of 1 ml chloroform and 0.75 ml NaC1 (1 M) with 
vortex, followed by 1 ml chloroform and 1 ml NaC1 with vortex. 
Phase separation occurred after centrifugation at 500 g for 2 rain. 
After measuring the volume of the chloroform phase, a 0.4-ml 
sample was removed and dried under nitrogen. The samples were 
dissolved  in chloroform  (40/~1), and 30/~1 of  each sample  was spotted 
onto TIC plates (24, 26, 27) (Whatman Inc., Clifton, NJ). E. coli 
DAG kinase is stereospecific  for sn-l,2-DAGs and does not detect 
2,3- or 1,3-DAG (26). 
The PL were separated using chloroform/glacial acetic acid 
(130:30:10 vol/vol/vol). Radioactive spots visualized  by autoradio- 
graphy corresponding to DAG standard  were collected,  dissolved in 
scintillation solution and [32P]PA, and quantitated by fl-emission 
using a liquid scintillation  counter (model 1214 Rackbeta|  Pharmacia 
Inc., Gaithersburg, MD). The amount of 1,2-DAG present was 
calculated from a standard curve using 1,2-DAG (in nM) 10, 3, 1, 
0.3, 0.1, and 0.03 (26, 27) (Avanti  Polar Lipids Inc., Alabaster, AL). 
E. coli DAG kinase also catalyzes the phosphorylation of cera- 
mide (26). Ceramide (Sigma Chemical Co., St. Louis, MO)  in 
amounts of gl0 ng, admixed with 1,2-DAG in amounts of ~<10 
nM, did not compete for phosphorylation. Furthermore, the reso- 
lution of phosphorylated 1,2-DAG and ceramide was not effected 
and, typically, they separated from each other by at least 4 cm on 
TLC (data not shown). 
PL was quantitated by the phosphate assay  of Ames and Dubin 
(26-28) using 200 gl of the lower phase of the chloroform/meth- 
anol/EDTA extract of the cell pellet. The amount of DAG pro- 
duced is expressed as pmol/gg of PL (26, 27). Total PL in each 
sample was 1 _+ 0.2 gg (SD). The percentage of control in DAG 
was calculated  as 100 x [(experimental  in pmol per #g of  PL)/(con- 
trol in pmol per/xg of PL)]. 
Intracellular  Ionized Calcium  Measurements.  Monocytes,  U937 
cells, monocyte-depleted  (mixed) B and T cells, and murine CTLL 
cell line stably transfected with human Ib4R` (CTLL-hu-IL4-R) 
were loaded with the fluorescent intracellular Ca  z§  chelator dye, 
Fura-2, by incubating cells with 3 gM Fura-2 acetoxymethyl  ester 
(Fura-2-AM) (Molecular Probes, Inc., Eugene, OR.) for 30 min at 
37~  in Fura buffer as previously described (29-31). Fura buffer 
is composed of(in raM): 140 NaC1, 2.5 KC1, 2 CaC12, 5 MgC12, 
5 glucose, and 10 Hepes, pH 7.2. Fura-2-AM is metabolized to 
Fura-2, a membrane impermeant form, by cytosolic  nonspecific  es- 
terase. After loading, the cells were washed once and resuspended 
in Fura buffer containing 1 mM CaC12. Ca2+-dependent fluores- 
cence was measured in a Photon Counting Spectrofluorometer 
(model 8000C; SLM-AMINCO, Urbana, IL), interfaced with an 
1458  IL-4R Activates a Phosphatidylcholine-specific  Phospholipase C IBM PS/2 computer using the Fura-2 software (SLM). Experiments 
were performed at  room  temperature using 2  x  10  ~ cells per 
sample. The excitation wavelengths were 340 and 380 nm and the 
emission wavelength was 510 nm. Cytosolic Ca  2+ flux in response 
to IL-4 (10-50 ng/ml), ionomycin (1 #M), N-FMLP, or leukotriene 
B2 (LTB4)  was  determined by measuring the excitation ratio of 
340/380 for Fura-2 (excitation wavelength for the Ca  2§ saturated 
form is 340 nm, and for the Ca2+-free  Fura-2, 380 rim).  Intra- 
cellular Ca 2+  concentration was  calculated with  the  following 
equation (29): [Ca2+]i  =  Ka  x  F,  ig  ￿  [(g  -  Rmm)/(Rm=  -  R)], 
where Kd is the effective dissociation  constant, R  is the relative 
fluorescence ratio of 340/380 at any time point; Rm~ and Rm~x are, 
respectively,  the minimum  and maximum fluorescence ratio of 
340/380 for minimum Ca  2+  after chelation by EGTA and max- 
imum in which all dye has bound Ca  2  +; Fsig is the bound signal 
fluorescence  ratio of 340/380. 
Inositol Phosphates Measurement.  Monocytes (2  x  106 in dupli- 
cate) were labeled with myo-2-[3H]inositol  (2 #Ci/ml, Amersham 
Life Sciences) in complete medium containing 2% AB serum for 
72 h. The cells (16  x  125-mm glass tubes) were resuspended in 
fresh  medium  after  centrifugation  at  250 g  for  10  min,  and 
equilibrated with 10 mM LiC1 for 1 h [32], 37~  before stimula- 
tion with FMLP (50 gM), ionomycin (10/~M), and IL4 (50 ng/ml). 
The reaction was stopped with ice cold methanol and the samples 
were placed on dry ice. Released inositols were extracted from cells 
with chloroform/methanol/HC1/(100:100:1, vol/vol/vol) (33, 34). 
Pooled upper phase  was dried with N2 and resuspended in 3 ml 
ion-flee H20. Inositol phosphates  were separated by 50% (wt/vol) 
slurry of  Dowex-1 (0.5 ml, 100-200 mesh. A-61X-5) column. After 
loading the sample onto the column, the sample was eluted with 
5 mM myo-inositol/0.1 M formic acid. Inositol phosphates, IPl, 
IP2, and IP3, respectively,  were eluted from the column by step- 
wise addition (each 6 ml) of 0.2, 0.4, and 0.8 M ammonium for- 
mate (33). The eluants were dissolved in scintillant  and counted 
by B-emission for calculation of total, and for each form of inositol 
phosphate. 
Measurement of Membrane PL and Metabolites.  U937 cells and 
monocytes were cultured with complete medium containing 2% 
AB serum and methyl-[lgC]choline (chol) (1 gCi/ml, sp act, 56.4 
mCi/mmol; Amersham Life Sciences) as previously described (21). 
Cells were serum starved for 4 h in complete medium supplemented 
with 2% BSA. Aliquots of cells (in 12 x  75-mm glass tubes) were 
suspended in PBS, pH 7.2, and treated with PBS or PBS containing 
IL-4 at 37~  In other experiments, the effect of IL-4 was com- 
pared with exogenously added phospholipases  (Sigma  Chemical 
Co.): PC-specific  PIC (5  x  10 -2 U/ml, Bacillus cereus, [P6135]) 
(35), sphingomyelinase (SMase; 10 -3 U/ml, Staphylococcus aureus) 
(36, 37), and phospholipase D (PLD; 0.5 U/ml, Streptomyces chro- 
mofuscus). 
The reaction was stopped by immersion of the tubes in meth- 
and/dry ice (- 70oC) for 10 s. Cells were centrifuged in a microfuge 
to obtain supernatant and pellet and processed as previously de- 
scribed (21). The supernatants were collected for determination of 
extracellular  water  soluble  methyl-[14C]chol  metabolites.  The 
pellet was resuspended  in cold CHsOH/CHCh/HzO (2.5:1.25:1, 
vol/vol/vol),  vortexed, and separated  into aqueous and organic 
phases containing the respective cell-associated [l~C]chol metabo- 
lites  and 14C-PL (21). Aliquots of the aqueous and lipid phases 
were dried under nitrogen and resuspended in 50% ethanol and 
chloroform, respectively.  The water-soluble fractions were sepa- 
rated on thin-layer silica phtes using the following separation system: 
CH3OH/0.5% NaC1/NH4OH (100:100:2, vol/vol/vol). PL were 
separated  by  TIC  using  a  solvent  system containing  CHCh/ 
CH3OH/CH3COOH/H20  (100:60:20:5;  vol/vol/vol/vol) (21, 
38). Glycerolphosphocholine (GPC), pehol, chol, PC, sphingomyelin 
(SM) and LPC (Sigma Chemical Co.) were used as standards.  The 
resolved products were visualized in iodine vapor. Autoradiography 
was performed to determine the location of  each metabolite. Meta- 
bolites corresponding to the standards  were cut out, dissolved in 
scintillant,  and counted by B-emission. 
Measurement of  PA, Phosphatidfl-Ethanol (PEt) and DAG for PLD 
Activity.  Serum-starved U937  cells  were labeled  for 2  h  with 
t-lyso-3-PC, 1-[1-14C]palmitoyl at 1 mCi/ml (sp act, 56.8 mCi/ 
mmol, Amersham Life Sciences) as previously described (21). U937 
cells, untreated or treated with  1% ethanol for 2 min or with 
200/~M propranolol for 5 min were incubated with medium or 
medium  containing  100  ng/ml  IL-4 for indicated  times.  Cells 
were equally divided for quantitation  of PA or PEt  and DAG. 
14C-labeled PEt or 14C-labeled PA was separated by TIC and quan- 
titated by the method described for membrane PL and metabolites. 
In the split  cell sample,  DAG was quantitated by E. coli kinase. 
Effect of  PA Phosphohydrolase  (PAP) and Protein Phosphatase Inhibi- 
tots.  Human monocytes, U937 cells, and PMN were either not 
treated or treated with propranolol (200/~M) (39) or calyculin A 
(100 riM) (40, 41), and stimulated with either medium or medium 
containing IL-4 (10 ng/ml)  or FMLP (5 gM). The generation of 
DAG at 10 min of stimulation was measured and expressed  as a 
percentage of control (medium). In additional experiments, serum- 
starved  U937  cells  labeled  for 2  h  with  r-lyso-3-PC,  1-[1-14C] 
palmitoyl at 1 mCi/ml were either untreated or treated with 200 #M 
propanolol for 5 rain and incubated with medium or medium con- 
taining 100 ng/ml IL-4. The 14C-labeled PA produced from these 
conditions was quantitated. 
Measurements of  Arachidonate.  Monocytes obtained by differen- 
tial adherence and harvested by a rubber policeman were plated 
onto 13-mm glass coverslips in 24-well plates (2  x  106/ml/well). 
After incubation for 20 h at 37~  in 5% CO2, monocytes were 
labeled  with  [3H]arachidonic  acid  (1  gCi/well,  100  Ci/mmol, 
New England Nuclear, Bedford, MA) for 20 h at 37~  (42, 43). 
Unincorporated [3H]arachidonate  was removed by washing with 
warm  saline  containing  1%  BSA.  After  the  addition  of fresh 
medium, ceils were equilibrated for 10 min at 37~  before the ad- 
dition of medium or medium containing stimuli into duplicate or 
triplicate wells. Supernatant (0.5 ml) was removed at the indicated 
time, and centrifuged at 500 g  for 1 min to pellet any detached 
cells. The amount of [3H]arachidonic  acid released was determined 
by counting for B-emission in scintillant. Stimulus-induced release 
of arachidonic  acid  was  expressed  as  a  percentage  of control 
(medium). 
StatisticalAnalysis.  Student's t test of paired samples was used, 
and values are expressed as mean  +  SEM unless otherwise indi- 
cated, n equals  the number of individual experiments performed 
using different donors or cell lines from different culture dates. 
Results 
IL-4 Induced a  Time-dependent Increase  in the Production  of 
1,2-DAG.  IL-4R signaling involves PKC translocation. Since 
PKC is activated by DAG, the production of DAG in response 
to IL-4 was  examined.  IL-4 induced  a time-dependent  in- 
crease  in  production  of  1,2-DAG  for both  U937  human 
promonocytic cells and monocytes. Fig.  1 A  illustrates  the 
production of DAG from U937 promonocytic cells. Basal DAG 
was low and IL-4 (10 ng/ml) induced a time-dependent in- 
crease in the generation of DAG that reached 335  _+  36% 
of control at 10 rain. Statistically significant increase in DAG 
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Figure  1.  Production of 1,2-DAG  by human U937 promonocytic cells 
and monocytes induced by IL-4 (10 ng/ml) and FMLP (5/zM) expressed 
as percentage of control. (A) Production of DAG by U937 cells. Basal 
DAG for U937 was 134 + 44 pmol/#g of PL. Exposure  to I124  (10 ng/ml) 
at 37~  for 0.25, 0.5, 1, 5, and 10 min induced DAG production, respec- 
tively, 213 + 45, 290 •  55", 322 •  50", 420 .+ 59", 449 ,+ 43" prnoi//~g 
PL, compared  to basal DAG, *p <0.05 (Student's t test, n = 5). (B) Produc- 
tion of DAG by monocytes. Basal DAG was 286 .+ 28 pmol/t~g of PL. 
In response to Ib4 (10 ng/ml) DAG production at 0.5, 1, 5, and 10 rain 
was 435 .+ 62*, 538 .+ 66*, 752 _+ 48*, 891 _+ 46* pmol/~g PL, com- 
pared to basal DAG (*p <0.05, paired Student's t test; mean _+ SEM, n = 4). 
was noted for stimulation of >10.5 min (compared to basal 
DAG, p  <  0.05,  Student's t test,  n  =  5-8).  Fig.  1 B  illus- 
trates the production of DAG by human monocytes. Basal 
DAG was 286  _+  28 pmol/#g PL, and IL-4 (10 ng/ml) in- 
duced a time-dependent increase in the amounts of DAG that 
rose to 314  _+  17%  at  10 min.  Statistically significant in- 
crease was  demonstrated  for an exposure time  of ~1  min 
(compared to basal DAG, p <0.05, Student's t test, n  =  4-6). 
FMLP,  another  receptor  ligand,  induced  a  similar  time- 
dependent increase in DAG in U937 cells and monocytes (Fig. 
1, A  and B). 
The production of DAG in response to increasing concen- 
trations of IL-4 and FMLP was studied to provide further 
evidence for receptor-associated generation of DAG.  Fig.  2 
illustrates the generation of DAG by U937 cells in response 
to IL-4 (/1) and FMLP (B). IL-4 and FMLP induced a dose- 
dependent increase in the production of DAG. Maximal in- 
crease  in  DAG  of 625  _+  25  pmol//~g  PL  (248%  above 
medium) was observed with IL-4 at  10 ng/ml,  a dose that 
corresponds to the reported peak functional and PKC response 
in IL-4-treated macrophages (23). The stepwise increase in 
DAG was statistically significant for IL-4 doses >0.01 ng/ml 
and  FMLP doses >  0.1  nM  (n  =  4, p  <  0.05). 
IL-4 R  Signaling  Does Not Involve Cytosolic-free Cakium 
Flux.  Many ligand receptors on phagocytes are coupled to 
PLC that hydrolyzes PIP~ to inositol triphosphate (IP3) and 
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Figure 2.  Production of DAG (pmol//~g of PL) by U937 cells in re- 
sponse to increasing concentrations of II--4 and FMLP. II.-4 and FMLP 
induced a dose-dependent increase in production of DAG for 10 min at 
37~  Maximal increase in DAG observed with Ib4 at 10 ng/ml corre- 
sponds to the peak dose-effect  on functional and PKC response of macro- 
phages to IL-4. The stepwise increase  in DAG was statistically significant 
for II.-4 doses >0.01 ng/ml and FMLP doses >10- io M (p <0.05; mean _+ 
SEM, n  =  4). 
DAG (14, 16-18). The generation of IP3 leads to the release 
of calcium from intracellular stores or to entry of extracel- 
lular calcium from plasma membrane channels resulting in 
an elevation of cytosolic-free calcium (14). Exposure to IL-4 
(10-50 ng/ml) over a recording time of 10 min had no effect 
on calcium levels in monocytes, mixed B and T  cells, U937 
cells, and CTLL-hu-IL-4R  cells suspended in medium con- 
taining  1 mM or higher of Ca  2+.  As illustrated  in Fig.  3, 
monocytes, mixed B and T cells, U937 cells, and CTLL-hu- 
IL-4R cells remained responsive to ionomycin (1 #M) with 
measured peak cytosolic-free calcium ([Ca  2+ ]i) flux that was 
respectively 500, 380, 553, and 429% above basal (n  =  3-10). 
The peak [Ca  2  + ]i flux was not altered by pretreatment with 
IL-4. 
To further define that Fura-2-1oaded cells remained respon- 
sive to receptor stimuli, [Ca  2+ ]i flux of monocytes, and U937 
cells in response to FMLP,  and LTB4 were compared with 
ionomycin.  Monocytes  responded  to  FMLP,  LTB4,  and 
ionomycin with a [Ca2+]i  flux that was 255, 230, and 451% 
of basal (Table 1). Similarly, stimulation of U937 cells with 
FMLP and ionomycin resulted in peak  [Ca2+]i flux of 234 
and 445% of basal. Therefore, monocytes and U937 remained 
responsive to other receptor ligands  even though  IL-4 did 
not  trigger  a  [Ca2+]i  flux. 
IL-4R Signaling Does Not Involve the Generation of lnositol 
Phosphates.  To further evaluate whether PIP2 may be used 
for IL-4R signaling,  the generation  of inositol phosphates 
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Figure  3.  Intracellular calcium homeostasis in response to II,4 and cal- 
cium ionophore, ionomycin.  Representative  experiments  of monocytes, 
U937 cells, mixed B and T cells, and murine CTLL-hu-IL-4R cells loaded 
with Fura-2 and stimulated with medium or medium containing IL-4 and 
ionomycin 1/zM, are presented.  Basal cytosolic ionized calcium [Ca 2  +  ]i 
for monocytes,  U937 cells, B and T  cells, and murine CTLL-hu-Ib4R 
cells was, respectively, 144.9 _+ 7.8, 90.1 _+  13.6, 113.4 +  15.4, and 58.4 _+ 
5.1 nM (n  =  3-10).  Significant changes in [Ca2+]i, were not detected in 
response to Ib4 for each of the cell types with recordings  up to 10 min 
(n  =  3-10).  For example, basal [Ca 2+ ]i for monocytes  and mixed B and 
T cells was, respectively, 140  +  5.5 and 91  +  14.1. In response to I1.,4 
(10-50 ng/ml), increase in [Ca2+]i was not observed; at 10 min the mea- 
sured  [Ca2+]i for monocytes  and mixed B and T cells was  128  +  11.5 
and 87.6  _+  17.1 (n  =  9 and 5, respectively). In contrast,  ionomycin (1 
/~M) induced a peak [Ca2+]i  in monocytes, B and T cells, U937 cells, and 
CTLL-hu-IL-4R cells that was, respectively, 720.6  _+ 90.8, 342.5  _+  70.7, 
625.5  _+ 97.2, and 249.3  _+ 29.7 nM (n  =  3-10).  Prior stimulation with 
ID4  did not  influence  the detected  peak  calcium  flux in  response  to 
ionomycin.  The results  are expressed as mean  -+  SEM. 
from membrane PL was measured in monocytes prelabeled 
with myo-[3H]inositol.  FMLP (50/~M) and ionomycin (10 
/~M) but not IL-4 (50 ng/ml) induced the production of total 
inositol phosphates (Fig. 4 A). Similarly, treatment with FMLP 
and ionomycin (data not shown) resulted in a time-dependent 
production  of IP1,  IP2,  and IP3 but this was not observed 
with IL-4 (Fig.  3 B). The lack of detectable inositol phos- 
phates in response to IL-4 and the detection of inositol phos- 
phates in monocytes stimulated with FMLP, a stimulus known 
to elevate [Ca2+]i  and IP3,  suggest that  PIP2 is not a sub- 
strate for IL-4R signal  transduction. 
IL-4R Signaling Involves the Use of PC.  Since DAG is de- 
rived from phospholipase hydrolysis of either PIP2 or PC and 
cytosolic calcium flux, and inositol phosphates were not de- 
tected in response to IL-4, experiments were performed to 
determine whether PC is used and to define which phospholi- 
pase transduces IL-4R signal. Membrane PC was labeled with 
the precursor, methyl-[14C]chol,  to investigate whether PLC, 
PLD,  or PLA2 is coupled to IL-4R.  If PLC is involved in 
IL-4R signaling, increases  of pchol and unchanged amounts 
of chol or GPC, the respective enzymatic products of PLD 
and PLA2  hydrolyses of PC would be detected upon  IL-4 
treatment.  Similarly in response to IL-4, decreases  of mem- 
brane PC and unchanged amounts of other constituents, such 
as SM and lyso-pchol would be observed. 
U937 cells prelabeled with methyl-[t4C]chol were stimu- 
lated with medium or medium containing IL-4. The labeled 
membrane lipids and metabolites were each determined in 
the respective aqueous and lipid phases of cell extracts.  In 
the aqueous phase, IL-4 induced a dose- and time-dependent 
increase in the production of pchol (Fig. 5, A  and B). Max- 
imal generation of pchol was observed at 5 min with IL-4 
doses of 10 and 100 ng/ml,  156 and 203% of control (Fig. 
5, A  and B; n  =  5-7, F <  0.05 for exposure time of i> 1 
rain). Significant changes ofchol or LPC and GPC, the respec- 
tive products of PLD or PLAz hydrolysis of PC, were not 
detected. 
Analysis of the lipid phase of the cell extract demonstrated 
a concomitant dose- and time-dependent decrease in mem- 
brane PC (Fig. 6, A  and B). Compared to control, the max- 
imal changes in PC in response to IL-4 doses of 10 and 100 
ng/ml  were, respectively,  18 and 30%.  Furthermore,  IL-4 
at  a dose of 100 ng/ml  reached a  significant  nadir  for the 
maximal degradation of PC earlier than at 10 ng/ml,  15 and 
60 s, respectively (p <  0.05 compared to control, n  =  5-7). 
In the same cell preparations, significant  changes in LPC were 
not demonstrated.  Opposing changes in SM were observed 
in response to IL-4. Maximal decrease in membrane SM (26 
or 74% of control) was associated with IL-4 dose of 10 ng/ml 
at 1 min. In contrast, treatment with 100 ng/ml of IL-4 was 
associated with an increase in SM (19 or 119%  of control) 
at  1 min  (Fig.  6, A  and B). 
Table  1.  Chemotactic Ligands Induce Cytosolic-free Cakium  Flux  in Human Monocytes and U937 Promonocytic Cells 
Cytosolic  free calcium (riM) in response to: 
Cells  Basal  FMLP  LTB4  Ionomycin 
Monocytes  140.6  +  10.9  359.7  +  24.7  334.7  _+  56.1  634  _+ 90.8 
U937 cells  95.0  _+  11.5  269.1  _+  84.7  ND  503.2  +  56.3 
Fura-2  loaded cells were monitored for basal calcium.  A significant increase in cytosolic calcium was noted after stimulation with FMLP (0.5 #M), 
LTB4 (1 #M),  and ionomycin (1 kcM), but not for IL-4 (50 ng/ml).  The number of experiments  for monocytes  from different  donor and U937 
cells were, respectively,  4-10 and 4, F <0.05  compared  with basal. The results  are expressed as the mean  _+  SEM. 
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Figure  4.  Production ofinositol phosphates by monocytes. Monocytes 
previously labeled with [3H]myo-inositol were stimulated with FMLP (50 
/~M), ionomycin (10 ~M), and IL-4 (50 ng/ml). Illustrated are the genera- 
tion of: (A) total inositol phosphates  in response to three stimuli,  and 
(B) IP3, IP2, and IP1 in response to FMLP. Basal total inositol phosphates 
was 1,084  _+  175 cpm per 2  x  106 cells. Changes in total inositol phos- 
phates in response to IL-4 were not detected. In contrast,  the same cells 
generated significant increases  of total inositol phosphates in response to 
ionom)~in and FMLP at  5 and 25 min (p <0.05,  mean  _+  SEM, n  = 
4). Analysis of inositol phosphates detected in response to FMLP, but not 
to IL-4, the initial production of IP3,  and its rapid loss was followed by 
an increase of IP2 and a more sustained increase in IP1 (mean  _+  SEM, 
n  =  4). 
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To define further whether pchol was derived from PC hy- 
drolysis, we analyzed the incorporation  of [14C]chol into 
[14C]chol lipids or metabolites and their transformation in 
response  to  IL-4. Basal incorporation  of  [14C]chol into 
[14C]chol lipids  or metabolites  in  the lipid  and the water 
soluble phases was, respectively, 167,759  +_  17,842 (+_ SEM) 
per 106 U937 cells and 46,178  _+  1,873 per 106 U937 cells. 
Basal PC and pchol were, respectively, 159,302  _+  1,410 and 
44,155  _+  14,127 (n  --  4). In response to IL-4,  10 and 100 
ng/ml, peak reduction of PC (mean _+ SEM) was 28,674  _+ 
796 and 47,790  +_ 4,230 cpm/106 cells. The peak generation 
of pchol (above control) was 24,726  _+ 4,796 and 45,479  _+ 
A  IL-4  lO rig/m1 
B  IL-4  100  ng/ml 
i  ,  i  L  u 
1  2  3  4  5  6 
Time  (rain) 
Pchol  A-  -  A  Chol  ￿9 .... ￿9  GPC 
IL-4 induced a dose- and time-dependent increase in produc- 
tion of pehol. U937 cells prelabeled with methyl [14C]chol  (48 h) were 
resuspended in PBS or PBS containing lb-4. The experiment was termi- 
nated by chilling (at  -70~  for 10 s), centrifugation,  and extraction of 
the cell pellet with cold CH3OH/CHC13/H20  resulting in two aqueous 
and one lipid phases.  The aqueous phases  were examined for extra- and 
intracellular [1K~]chol metabolites: pehol, chol, and GPC. Significant in- 
creases in pchol were observed for time of II,4 exposure (10 and 100 ng/ml) 
of 1 min or greater (p <0.05, n  =  4) but not for chol and GPC. Maximal 
pehol was observed at 5 min of exposure to IL-4 doses of 10 and 100 ng/ml 
that were, respectively, 56 and 103%  change above control. The results 
are expressed as the mean  _+  SEM. 
14,550  cpm/106  cells (n  =  4).  The  amounts  of PC lost 
being equivalent to the amount of pchol produced, suggest 
that pchol  is derived from PC hydrolysis. 
IL-4R Signaling and PLD Activity.  DAG may be gener- 
ated as a secondary product of PLD catabolizing PC to form 
PA and chol. PAP removes the phosphate group from PA, 
resulting in DAG (15, 17, 21). To exclude the coupling  of 
IL-4R to PLD, we compared production of pchol and chol 
in response to IL-4 and exogenous PLD in [14C]chol-labeled 
U937 cells (Table 2). PLD, but not IL-4, induced the produc- 
tion of chol. In contrast, IL-4 treatment led to the genera- 
tion of pchol but PLD did not. Both IL-4 and PLD used 
PC for the generation of pchol  and chol, resulting  in the 
detected loss  of PC. 
To  exclude  further  the  involvement  of PLD  in  IL-4R 
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Figure 6.  IL-4  induced a dose- and time-dependent decrease in mem- 
brane PC. The lipid phase of cells treated with medium or medium con- 
taining Ib4 (see Fig. 5) was examined for [14C]chd lipids, PC, LPC, and 
SM. Significant  decreases  in PC were observed for ID4 treatment that was 
time- and dose-dependent. For Ib4, 10 ng/ml significant decreases  in PC 
were observed at 1 min, and for Ib4, 100 ng/ml significant decrease was 
seen at 15 and 30 s (p <0.05; mean _+  SEM, n =  4). Membrane PC de- 
crease in response to 10 and 100 ng/ml of I1.-4 at 1 rain and 15 s was, 
respectively, 18 and 30% below basal (control). Changes in LPC were 
not observed.  In contrast, treatment with IL-4  at doses  of 10 and 100 ng/ml 
was associated, respectively, with decrease and increase in SM. 
signaling, experiments were performed using L-lyso-3-PC, 
1-[1-14C]palmitoyl to label U937 cells at the glyceride por- 
tion of PC.  These cells were stimulated in the presence or 
absence of ethanol (Table 3).  Ethanol  substitutes for H20 
in the PLD  catalyzed cleavage of chol from  PC,  resulting 
in the formation of PEt instead of PA. As illustrated in Table 
3, both 11.-4 and PLD increased the population of DAG. Com- 
pared to control, treatment with PLD but not IL-4 increased 
PA by ",'200%.  Stimulating the cells with PLD  and PMA 
in the presence of ethanol resulted in the generation of PEt 
and the concomitant decrease in PA. Ethanol had no effect 
on the production of PEt in cells stimulated with IL-4. Fur- 
thermore, ethanol reduced the amount of DAG produced in 
response to PMA and exogenous PLD, but had no effect on 
the increase in DAG triggered by IL-4. 
Effect of Inhibitors of PAP on the Production of DAG.  To 
Table  2.  Production  of  Pchol and Chol by U937 Promonocytic Cells 
Percentage of control (mean  _+  SEM) 
Pchol  Chol  PC  SM 
IL-4 (100  ng/ml) 
15  s  130  _+  6  102  +  5  76  _+  4  103  _+  4 
5min  183  +  22  103  _+  4  90  +  5  116  _+  10 
PLD  (0.5 U/ml) 
15  s  99  +  1  150_+  2  94  +  1  113  _+  5 
5min  108  _+  3  140_+  4  85  +  3  95  _+  2 
u937 promonocytic cells prelabeled with methyl-[14C]chol  were treated 
with medium or medium containing IL-4 (100 ng/ml) or PLD (0.5 U/ml, 
Sigma Chemical Co.,) at 37~  The aqueous and lipid layers were ex- 
tracted and the specific  products were separated by TLC, identified by 
autoradiography  with comparison  to standards, and counted by E-emission. 
The results (mean _+  SEM) of three experiments are expressed  as the per- 
centage of medium (control). 
Table  3.  Production  of DAG, PEt, and PA by U937 Cells 
Percentage of control (mean  +_  SEM) 
1,2-DAG  PEt  PA 
IL-4 (100  rig/m1) 
5 min  224  +  44  ND  93  +  4 
10 min  294  _+  57  ND  97  _+  2 
IL-4  +  1%  ethanol 
5 min  206  +  23  101  _+  15  115  +  7 
10 rain  267  +  70  71  +  30  100  _+  1 
PMA (100 riM) 
20 min  469  _+  105  ND  278  +  15 
PMA  +  1%  ethanol 
20 min  141  +  10  245  _+  90  116  _+  13 
PLD  (0.5 U/ml) 
5 min  247  +  65  ND  147  _+  11 
10 min  276  +  41  ND  180  _+  10 
PLD  +  1%  ethanol 
5 min  104  +  1  206  _+  45  109  _+  5 
10 rain  79  +  4  197  _+  45  119  +  3 
Serum-starved U937  cells were  labeled for  2  h  with  L-|yso-3-PC, 
1-[1-14C]palmitoyl at 1 mCi/ml. U937 cells untreated or treated with 
1% ethanol for 2 min were incubated with medium, and medium con- 
taining IL-4 (100 ng/ml), PMA (100 riM), or PLD (0.5 U/ml) for the 
indicated times. Cells were equally divided for quantitation of PA or PEt, 
and DAG. 14C-labeled  PEt or 14C-labeled  PA were separated by TLC 
and quantitated by the method described for membrane PL and metabo- 
lites. In the split cell sample, DAG was quantitated  by E. coli kinase. 
The results (mean +_  SEM) of four separate experiments are expressed 
as the percentage of control  (medium). 
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exclude the possibility that IL-4R might be linked to a PLD 
with. more rapid catalytic activity than exogenous PLD, we 
examined the effect of propranolol and calyculin A, the respec- 
tive inhibitors  of PAP and protein phosphatases, on IL-4- 
induced production of DAG in U937 cells and monocytes. 
Parallel experiments using human PMN were performed to 
serve as controls since receptors for FMLP and C5a are cou- 
pled to PLD in human PMN, and their signaling is inhibited 
by propranolol  and calyculin (39, 40). 
Illustrated in Fig. 7 A is the effect of propanolol on IL-4- 
and FMLP-stimulated  production of DAG by U937  cells, 
monocytes, and PMN. Propanolol did not affect the IL-4- 
induced production of  DAG by U937 ceils (n = 5) and mono- 
cytes (n =  2), but abrogated the FMLP-induced generation 
of DAG by PMN (p <  0.05 propranolol  with FMLP com- 
pared to FMLP, n =  5, Fig. 7 A). Since propranolol inhibits 
the activity of  both PAP and PKC (39, 40), experiments were 
performed with calyculin A, a potent inhibitor of phospha- 
tase 1 and 2A (40, 41) (Fig. 7 B). Calyculin A significantly 
inhibited the production of DAG induced by FMLP but not 
that by IL-4 (p < 0.05 calyculin A and FMLP compared to 
FMLP, n  =  5). 
To provide additional evidence that IL-4R is not coupled 
to PLD, we used a PL precursor radiolabded at the glyceride 
portion of the molecule. U937 ceils labeled with L-lyso-3-PC, 
1-[1-14C]palmitoyl were stimulated  in the presence or ab- 
sence of propanolol (Table 4). In the presence of propanolol, 
radiolabded PA accumulated in response to PMA but not 
to IL-4. In addition,  the amount of DAG detected was re- 
duced in response to PMA but not to IL-4. These findings 
provide multiple evidence that IL-4R signaling does not in- 
volve PLD activation. 
Measurement of  Arachidonic Acid Generation.  Receptor fig- 
naling through PLA2 may result in the formation of DAG. 
PLA2 catabolizes PC to form the intermediate metabolites 
GPC and LPC; PA and DAG are generated by the addition 
of acyl groups  to glycerol 3-phosphate  (15, 21). Although 
Table  4.  The Effect of Propranolol on the Production of 
DAG and PA 
Percentage  of control 
(mean  •  SEM) 
1,2-DAG  PA 
IL-4 (100  ng/ml) 
5  min  146  •  15  93  _+  4 
10 min  190  _+  16  97  •  2 
IL-4  +  propranolol  (200  #M) 
5  min  157  _+  1.4  98  _+  5 
10 rain  169  _+  3.5  106  _+  2 
PMA (100  riM) 
20 min  205  •  17  137  •  2 
PMA  +  propranolol  (200/~M) 
20 min  112  •  1  220  •  10 
Figure  7.  Effect of PAP and phosphatase  1 and 2A inhibitors  on DAG 
production by U937 cells, PMN, and monocytes.  Cells were suspended 
in medium or medium containing propanolol  (200/~M,  A) or calyculin 
A (100 riM, B) for 5 min at 37~  before the addition  of ID4 10 ng/ml 
or FMLP (5/~M) for an additional 10 rain at 37~  Propranolol and calyculin 
A had no effect on IL-4-induced DAG production in U937 cells and mono- 
cytes. In contrast, propranolol and calyculin A significantly inhibited PMN 
production of DAG in response to FMLP (p <0.05;  mean  _+  SEM, n = 
4 except monocytes  n  =  2). 
Serum-starved  U937  cells  were  labeled  for  2  h  with  L-lyso-3-PC, 
1-[1-14C]palmitoyl at  1 mCi/ml. U937 cells untreated or treated  with 
200/~M propranolol for 5 rain were incubated  with medium, and me- 
dium containing  100 ng/ml IL-4 or 100 nM PMA for the indicated times. 
Cells were equally divided for quamitation of PA and DAG. 14C-labeled 
PA was separated by TLC and quantitated  by the method described for 
membrane  PL and metabolites.  In the split cell sample, DAG was quan- 
titated by E. coli  kinase. The results (mean  _+  SEM) of two separate ex- 
periments  are expressed  as the percentage  of medium (control). 
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not detected in response to IL-4, experiments were performed 
to measure arachidonic  acid, the first cleavage product of 
PLA2.  Human  monocytes  prelabeled  with  extracellular 
[3H]arachidonate were stimulated with medium or medium 
containing IL-4 (50 ng/ml), FMLP (5/~M), PMA (10/~M), 
calcium ionophore, A23187 (5 #M), and PMA plus A23187. 
Fig. 8 illustrates the significant production of extracellular 
[3H]arachidonate in response to FMLP, A23187, and PMA 
with A23187. In contrast, IL-4 or PMA alone had no effect 
on production of arachidonate. These findings suggest that 
IL-4R is not coupled  to PLA2 (Figs. 5, 6,  and 8). 
Involvement  of SM Metabolism  in IL-4R  Signaling.  That 
SM levels were altered in response to IL-4 led to the evalua- 
tion of SMase activity in response to IL-4 (19). Monocytes 
labeled with methyl-['4C]chol were studied for PC and SM 
catabolism and pchol generation in response to IL-4 and ex- 
ogenous PLC and SMase. Tables 2 and 5 indicate that IL-4 
induced pchol generation and membrane PC reduction that 
were comparable  to exogenous  PC-specific PLC,  without 
significantly reducing SM levels. Exogenous SMase reduced 
the amount of membrane SM and also induced slight increases 
ofpchol and PC. We further evaluated the effect of IL-4 and 
exogenously added SMase on the kinetics of DAG and on 
ceramide generation. Exploiting the finding that E. coli DAC 
kinase phosphorylates both DAG and ceramide (27, 36, 37), 
the response to IL-4 and exogenously added SMase is illus- 
trated on Table 6. IL-4 induced the generation of DAG but 
not ceramide. In contrast, exogenously added SMase induced 
the generation of ceramide that was maximal at 30 min. The 
Table  5.  Production of Pcholine  from Membrane PL 
Percentage of control (mean  _+  SEM) 
Pchol  PL  SM 
1I.-4  (100 ng/ml) 
15  s  135.0  +  10.0  67.6  _+  3.3  96.5  +  2.0 
5  rain  201.0  +  19.0  82.0  _+  2.0  124.0  _+  17.0 
PLC 
15  s  187.0  +_  10.0  73.0  _+  6.5  95.0  _+  5.0 
5  rain  237.0  _+  21.0  82.0  _+  8.0  109.0  _+  12.0 
SMase 
15  s  127.5  _+  1.0  115.8  _+  9.5  114.0  +  10.0 
5  rain  109.5  _+  2.5  117.0  _+  10.0  89.0  _+  2.0 
Monocytes prelabeled with methyl-['4C]-chol  and washed were treated 
with medium or medium containing  IL-4 (100 ng/ral), PC-specific PLC 
(5  x  10 .2 U/m1, Sigma Chemical Co.), and SMase (10 -3 U/ml, Sig- 
ma Chemical Co.) for 15 s and 5 min at 37~  The aqueous and lipid 
layers were extracted and the specific products  were separated by TLC, 
identified by autoradiography  with comparison to standards, and count- 
ed by 15-emission.  The results (mean  _+  SEM of three experiments) are 
expressed as the percentage of medium (control). 
Table  6.  Production of DAG and Ceramide  from  U937 
Promonocytic Cells 
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Figure 8.  Stimuli-induced generation of arachidonic acid by monocytes 
prelabeled with [3H]arachidonic acid. After washing to remove unincor- 
porated [3H]arachidonate  and equih'bration with fresh medium for 10 min 
at 37~  medium or medium containing  11,4 (50 ng/ml), FMLP (5/~M), 
PMA (10/*M),  and calcium ionophore (A23187, 5/~M) was added for 
an additional  10 rain at 37~  Release of 13H]arachidonic acid into the 
supematant was expressed as a percentage of medium (Control). Basal  release 
of arachidonic acid from control cells was 2,041  _+ 243 per well. FMLP 
and A23187 or A23187 with PMA, but not I1,4 and PMA, induced 
significant release of arachidonic acid (mean _+  SEM, n  =  3), p <0.05. 
Percent of control (mean  _  SEM) 
Condition and time  DAG  Ceramide 
IL-4 (10 ng/ml) 
0  min  116  _+  10  96  _+  4 
5  min  230  _+  2  108  _+  8 
30 min  129  +  17  89  +  4 
SMase (10 .3 U/ml) 
0  min  119  +  1  103  +  3 
5  min  143  +  17  128  +  6 
30 rain  120  _+  4  208  _+  13 
U937 promonocytic cells were treated  with medium or medium con- 
raining IL-4 (10 ng/ml), and SMase (10 -3 U/ml) at 37~  Termina- 
tion of the assay immediately after the addition of stimuli was designated 
as time zero. Ceils were pelleted and extracted with chloroform/methanol 
(1:1, vol/vol); the lower phase containing  DAG, ceramide, and PL was 
evaporated under nitrogen. E. coli  DAG kinase was used to catalyze the 
transfer of 32PO4 from 3,-[32p]ATP to DAG and ceramide. The specific 
products  and their respective standards were  separated by TLC, iden- 
tiffed by autoradiography  with comparison to standards, and counted by 
fl-emission. The results (mean _+ SEM of three experiments) are expressed 
as the percentage  of medium (control).  Control DAG was  144  _+  18 
pmol/#g PL, and ceramide was 53  _+ 9 pmol/#g PL. 
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Figure 9.  IL-4 (10 ng/ml) induced the generation of DAG but not cer- 
amide in  monocytes.  Cells were pelleted and  extracted with  chloro- 
form/methanol (1:1, vol/vol), and the lower phase containing DAG, cera- 
mide, and phospholipids was evaporated under nitrogen. E. coli DAG kinase 
catalyzed the transfer of 32pO4 from 3,-[32p]ATP to DAG and ceramide. 
The specific products and their respective standards were separated by TIC 
and identified by autoradiography with comparison to standards. The results 
are the mean (_+  SEM) of three experiments. 
potential activation of SMase by IL-4P, was further excluded 
in monocytes by the simultaneous measurements of DAG and 
ceramide. Illustrated in Fig. 9 is the time-dependent produc- 
tion of DAG induced by IL-4 (10 ng/ml) without significant 
changes in ceramide.  The slight reduction of ceramide and 
the production of DAG induced by IL-4 (10 ng/ml) and ex- 
ogenous SMase, respectively, suggest cross-talking between 
these signaling pathways. 
Discussion 
IL-4,  initially described as a B cell growth and differen- 
tiating factor, plays an important role in Th-2 cell function 
and downmodulation of immune response in parasitic and 
HIV infection (7), and has been implicated in the pathogen- 
esis of leishmaniasis (4-7). The role of IL-4 in leishmaniasis 
may be due in part to its potent inhibition of cytokine activa- 
tion of macrophages (9-11).  Receptor signaling has been 
hypothesized to provide the specific input for modulating cell 
function. Although the hu-IL-4R has been cloned, DNA 
sequence analysis revealed no homology to known tyrosine 
or serine/threonine protein kinases. We reported previously 
that IL-4P, signal transduction involved PKC translocation 
to a nuclear fraction. The earlier IL-4R signaling events leading 
to PKC activation are examined in this report. 
IL-4 induced a time- and dose-dependent production of 
DAG. The maximal dose and kinetics of DAG generation 
induced by IL-4 paralleled the translocation of PKC previ- 
ously reported for IL-4-treated monocytes (23). As for PKC 
translocation, DAG production was near maximal at 5 rain 
of IL-4 treatment and for IL-4 dose of 10 ng/ml. The source 
of DAG is not derived from PIP2 hydrolysis, since neither 
inositol phosphates nor cytosolic calcium flux was detected. 
The absence of detectable calcium flux and PIP2 hydrolysis 
metabolites in monocytes and U937 promonocytic cells, and 
the absence of detectable calcium flux in monocytic cells, mixed 
B and T cells and murine CTLL cell line expressing IL-4R 
are in agreement with studies in murine B cells (for a review 
see reference 22; 44, 45) but are in contrast to results in human 
B cells reported by Finney et al. (46, 47). Although we are 
not able to explain this difference, our data suggest that DAG 
is derived from sources other than PIP2. 
DAG may be derived from PC hydrolysis by PLC and PLD, 
indirectly by PLA2, or by exchange of pchol between cera- 
mide and PC to generate SM and DAG (15, 16-19). In methyl 
[14C]chol-labeled U937 and monocytes, IL-4 induced a dose- 
and time-dependent production of pchol and degradation of 
PC. The finding that the amount of pchol gain equaled that 
of PC loss supports the suggestion that pchol is the hydro- 
lysis product of PC. In these samples, metabolites of PLD 
or PLA2, respectively chol or LPC and GPC, were not de- 
tected, suggesting that PLC activation is associated with IL- 
4R signaling. 
Additional experiments were performed to exclude PLD 
or PLA2, in IL-4R signaling. PLD hydrolysis of PC leads 
to the formation of chol and PA (Tables 2 and 3). Ethanol, 
which substitutes for H20  in the  transphosphatidylation 
reaction catalyzed by PLD (15, 21), decreased the generation 
of DAG in cells treated with PLD but not in those treated 
with IL-4 (Table 3). In the presence of ethanol, exogenous 
PLD treatment resulted in the formation of PEt whereas IL-4 
treatment did not. The formation of DAG from PA is cata- 
lyzed by the enzyme, PAP, which dephosphorylates PA to 
form DAG. The use of propranolol and calyculin A, the respec- 
tive inhibitors of PAP and phosphatase 1 and 2A (39-41), 
provides  additional evidence that the DAG detected in re- 
sponse to IL-4 is not derived from PLD hydrolysis of PC. 
Propanolol and calyculin A inhibited DAG production in re- 
sponse to FMLP but not to IL-4,  and propanolol inhibited 
the accumulation of 14C-labeled PA  in cells treated with 
PMA but not in those treated with IL-4 (Fig. 7 and Table 4). 
The involvement of PLA2 in IL-4P, signaling was also ex- 
cluded because neither intracellular and extracellular GPC and 
LPC, intermediate metabolites of PLA2 catabolism  of PC, 
nor extracellular  [3H]arachidonic  acid,  the direct cleavage 
product of PLA2, were detected in response to IL-4 (Figs. 
5, 6, and 8, Tables 3 and 4). In contrast, calcium ionophore, 
A23187,  and FMLP, but not IL-4,  induced the generation 
of AA in monocytes. Based on these additional findings, it 
is unlikely that PLD and PLA2 are involved in IL-4R sig- 
naling. 
Signaling for TNF-cz  and IL-1 has been reported to in- 
volve both SMase and PLC activation (35,  36).  Since data 
using  methyl  [t4C]chol-labeled  cells  showed  paradoxic 
changes in SM in response to IL-4 doses of 10 and 100 ng/ml 
(Fig. 6), experiments were performed to compare the effect 
of IL-4 and exogenously added PC-specific PLC and SMase. 
The generation of pchol and degradation of PC by IL-4 was 
similar to that of exogenous PLC (Table 2). SM levels were 
slightly increased as previously seen (Table 2 and Fig. 6). Only 
exogenous SMase induced degradation of SM. The finding 
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lysis of PC associated with IL-4 and exogenous PI.C occurred 
as early as 15 s is in agreement with previous reports (21, 
36,  37). 
Simultaneous measurements of DAG and ceramide were 
performed to exclude the possibility that the IL-4R might 
be linked to SMase which catalyzes ceramide production and, 
indirectly, DAG generation via exchange of pchol between 
PC and ceramide. In contrast to exogenous SMase, IL-4 in- 
duced the highest production of DAG whereas increased cer- 
amide production (with SM degradation) was detected only 
for exogenous SMase. Furthermore, the maximal activity for 
IL-4 and SMase was 5 and 30 min, respectively. The detected 
changes of SM or pchol and PC in response to IL-4 and ex- 
ogenous SMase probably result from the use of metabolites 
to regenerate different membrane lipids. The data presented 
suggest that IL-4R. signaling involves PC-specific PLC acti- 
vation and generation of DAG, which in turn activates PKC. 
Our findings also suggest that early IL-4R events do not in- 
volve the activation  of PLD, PLA2, or SMase. 
As stated by Liscovitch (18), "Activation of PIP2-specific 
PLC, PLD and PLA2 in whatever cell type-specific sequence 
appears to comprise  a signaling cascade which is typically 
utilized by most (if not all) Ca  2  +-mobilizing agonists" The 
observation that IL-4R signaling involves PC-specific PLC 
is strengthened by the contrast with FMLP, an example of 
Ca2+-mobilizing  agonist  that  involves PIP2-specific PLC, 
PLD, and PLA2 (18, 43, 48-50).  PIP2-specific PLC is com- 
posed of at least 16 isoenzymes belonging to the B, % and 
/t families of PLC. Members of these families  have been cloned 
and differ in their activation requirements by either G pro- 
teins  or  tyrosine kinases  (16). Unlike PIP2-specific PLC, 
much less is known about PC-specific PLC, although a bac- 
terial PC-specific PLC has been cloned (51). Evidence that 
PC-specific PLC is activated as part of receptor signaling is 
reported for TNF-c~, IFN-c~, IL-1, IL-3, and M-CSF  (21, 
52-55).  With the exception of TNF-ot, the involvement of 
PLD has not been excluded. Furthermore, cytosolic PLA2 
is activated by M-CSF  (56). 
TNF-otR, IFN-3,tL, and IL-1R involve SMase activation 
(36, 37, 57). In addition,  activation of PC-specific PLC has 
been reported for TNF-otR, IFNR (type I), and IL-1R (36, 
37, 52, 57). M-CSF binding to the tyrosine kinase M-CSFR 
leads to tyrosine phosphorylation of several  cytosolic proteins 
and the activation of PKC associated with PC hydrolysis and 
DAG formation (55), as well as induction of cytosolic PLA2 
activity and mRNA (56). In contrast, IL-4R activates only 
PC-specific PLC and not PIP2-PLC, PLD, PLA2, or SMase. 
This may provide an explanation for the fact that IL-4 down- 
modulates macrophages (9-11) whereas TNF-c~, IFN-% IL-1, 
and M-CSF activate maerophages for killing  of leishmania 
and for oxidative burst capacity (58, 59). PKC are reported 
to be involved in IL-1, IFN-c~, IFN-% IL-3, and IL-4 receptor 
signaling (60-64).  The specificity for modulation of macro- 
phage activation or downmodulation may be provided also 
by different isoforms of  PKC transducing these receptor ligands 
(13). One potential  mechanism by which specific PKC iso- 
forms are selectively coupled  to these receptors may result 
from differential use ofDAG isoforms that make up the many 
families of membrane phospholipids (65-69). Although not 
examined in this report, the results of Rosoff et al. (53) and 
Schultz et al.  (21) in studies of IL-1 and TNF-o~ receptor 
signaling, respectively, suggest that the activated PLC selec- 
tively uses membrane PC with specific  fatty acid side chains. 
Our report did not examine whether tyrosine kinase acti- 
vation may participate in IL-4R signaling. This possibility 
has been suggested recently in a murine myeloid cell line (70, 
71). Further evaluations are needed to determine whether selec- 
tive use of early signaling  pathways by different cytokines 
provides the specificity for up- or downmodulation of mac- 
rophage cell function. 
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